Allspring Global Investments’s Guardant Health GH Stock Holding History

Allspring Global Investments’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110M	Buy	646,509 +37,683	+6%	+$4.1M	0.17%	134
2026 Q1	$55.5M	Sell	608,826 -9,773	-2%	-$981K	0.09%	256
2025 Q4	$62.9M	Sell	618,599 -12,256	-2%	-$1.1M	0.1%	236
2025 Q3	$39.5M	Buy	+630,855	New	+$34.3M	0.06%	355
2024 Q2	–	Sell	-13,250	Closed	-$273K	–	2436
2024 Q1	$273K	Buy	+13,250	New	+$284K	﹤0.01%	1645
2023 Q4	–	Sell	-3,864	Closed	-$115K	–	2425
2023 Q3	$115K	Buy	+3,864	New	+$136K	﹤0.01%	1945
2022 Q1	–	Sell	-13	Closed	-$1K	–	3032
2021 Q4	$1K	Buy	+13	New	+$1.34K	﹤0.01%	2939

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Allspring Global Investments's GH Position: Q2 2026 in Review

Allspring Global Investments increased its Guardant Health (GH) stake by 6.2% in Q2 2026, buying an estimated $4.1M and bringing the position to 646,509 shares worth $110M. The position accounts for 0.17% of the portfolio, ranked #134.

Allspring Global Investments first reported a position in GH in Q4 2021 and has held it in 7 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Allspring Global Investments held 646,509 shares of Guardant Health worth $110M as of Q2 2026.
Allspring Global Investments bought 37,683 Guardant Health shares in Q2 2026, an estimated $4.1M.
Guardant Health made up 0.17% of Allspring Global Investments's portfolio in Q2 2026, its #134 holding.
Allspring Global Investments first reported a position in Guardant Health in Q4 2021 and has held it in 7 quarters since.
601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.